Form 4: Dianthus Therapeutics, Inc. /DE/ CFO Sells Shares
Insider Transaction (Form 4)
Ryan Savitz, EVP, CFO & CBO of Dianthus Therapeutics, Inc. /DE/, sold 31,249 shares of common stock on July 9, 2026.
Summary
- Option exercise/conversion: acquired 31,249 Common Stock at $21.77 ($680,291) on July 9, 2026; holds 31,249 after (Direct).
- Open-market sale: disposed of 10,354 Common Stock at $100.22 ($1,037,678) on July 9, 2026; holds 20,895 after (Direct).
- Open-market sale: disposed of 15,329 Common Stock at $101.24 ($1,551,908) on July 9, 2026; holds 5,566 after (Direct).
- Open-market sale: disposed of 5,566 Common Stock at $101.97 ($567,565) on July 9, 2026 (Direct).
- Option exercise/conversion: disposed of 31,249 Stock Option (Right to Buy) on July 9, 2026; holds 68,751 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $3,157,151 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Ryan Savitz — Officer (EVP, CFO & CBO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Option exercise/conversion | Common Stock | 31,249 | $22 | $680.3K | 31,249 |
| 2026-07-09 | Open-market sale | Common Stock | 10,354 | $100 | $1.0M | 20,895 |
| 2026-07-09 | Open-market sale | Common Stock | 15,329 | $101 | $1.6M | 5,566 |
| 2026-07-09 | Open-market sale | Common Stock | 5,566 | $102 | $567.6K | 0 |
| 2026-07-09 | Option exercise/conversion | Stock Option (Right to Buy) | 31,249 | — | — | 68,751 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Option exercise/conversion (31,249 shares) |
| 2026-07-09 | Open-market sale (10,354 shares) |
| 2026-07-09 | Open-market sale (15,329 shares) |
| 2026-07-09 | Open-market sale (5,566 shares) |
| 2026-07-09 | Option exercise/conversion (31,249 shares) |
Keywords
insider transaction, Form 4, DNTH, Dianthus Therapeutics, Inc. /DE/, bearish, Ryan Savitz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.